Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.

about

Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications.

P2860

Q39171230-268ADDB0-ECBC-4BAF-A5FC-722FFBCC04D5

P2860

Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.

Item

http://www.wikidata.org/entity/Q48089546

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.

@en

Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.

@nl

type

Item

label

Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.

@en

Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.

@nl

prefLabel

Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.

@en

Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.

@nl

P1476

Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization

@en

P2093

Doru Vornicescu

http://www.w3.org/2001/XMLSchema#string

Jana Brüßler

http://www.w3.org/2001/XMLSchema#string

Michael Keusgen

http://www.w3.org/2001/XMLSchema#string

Wegderes Endreas

http://www.w3.org/2001/XMLSchema#string

P2860

Non-additivity of functional group contributions in protein-ligand binding: a comprehensive study by crystallography and isothermal titration calorimetry

Ligand binding stepwise disrupts water network in thrombin: enthalpic and entropic changes reveal classical hydrophobic effect

Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface coupling

A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?

Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone

Development and characterization of new nanoscaled ultrasound active lipid dispersions as contrast agents.

Impact of albumin on drug delivery--new applications on the horizon.

Thrombin-inhibiting nanoparticles rapidly constitute versatile and detectable anticlotting surfaces.

The cyclization of peptides and depsipeptides.

Human erythropoietin dimers with markedly enhanced in vivo activity.

P304

340-349

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CMDC.201500489

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Udo Bakowsky

Torsten Steinmetzer

P577

2015-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26662675

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.

about

P2860

P2860

Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921